SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000939767-23-000064
Filing Date
2023-06-02
Accepted
2023-06-02 21:50:18
Documents
3
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1685757008.html 3  
1 FORM 3 wk-form3_1685757008.xml 3 1620
2 EX-24.POA exhibit24-poa.htm EX-24.POA 4290
3 exhibit24-poa001.jpg GRAPHIC 282233
  Complete submission text file 0000939767-23-000064.txt   396290
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Heyman Tomas J. (Reporting) CIK: 0001814673 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30235 | Film No.: 23991091